BMP2-induced Apoptosis Is Mediated by Activation of the TAK1-p38 Kinase Pathway That Is Negatively Regulated by Smad6
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Bone morphogenetic protein 2 (BMP2), a member of the transforming growth factor-beta (TGF-beta) superfamily, regulates a variety of cell fates and functions. At present, the molecular mechanism by which BMP2 induces apoptosis has not been fully elucidated. Here we propose a BMP2 signaling pathway that mediates apoptosis in mouse hybridoma MH60 cells whose growth is interleukin-6 (IL-6)-dependent. BMP2 dose-dependently induces apoptosis in MH60 cells even in the presence of IL-6. BMP2 has no inhibitory effect on the IL-6-induced tyrosine phosphorylation of STAT3, and the bcl-2 gene expression which is known to be regulated by STAT3, suggesting that BMP2-induced apoptosis is not attributed to alteration of the IL-6-mediated bcl-2 pathway. We demonstrate that BMP2 induces activation of TGF-beta-activated kinase (TAK1) and subsequent phosphorylation of p38 stress-activated protein kinase. In addition, forced expression of kinase-negative TAK1 in MH60 cells blocks BMP2-induced apoptosis. These results indicate that BMP2-induced apoptosis is mediated through the TAK1-p38 pathway in MH60 cells. We also show that MH60-derived transfectants expressing Smad6 are resistant to the apoptotic signal of BMP2. Interestingly, this ectopic expression of Smad6 blocks BMP2-induced TAK1 activation and p38 phosphorylation. Moreover, Smad6 can directly bind to TAK1. These findings suggest that Smad6 is likely to function as a negative regulator of the TAK1 pathway in the BMP2 signaling, in addition to the previously reported Smad pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K., & Hirano, T. (1996) · Immunity · doi:10.1016/s1074-7613(00)80501-4 · Cited by 652
Ishitani, T., Ninomiya-Tsuji, J., Nagai, S.-I., Nishita, M., Meneghini, M., Barker, N., Waterman, M., Bowerman, B., Clevers, H., Shibuya, H., et al. (1999) · Nature · doi:10.1038/21674 · Cited by 621
Meneghini, M. D., Ishitani, T., Carter, J. C., Hisamoto, N., Ninomiya-Tsuji, J., Thorpe, C. J., Hamill, D. R., Matsumoto, K., & Bowerman, B. (1999) · Nature · doi:10.1038/21666 · Cited by 293
Cited by
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Ying, Q.-L., Nichols, J., Chambers, I., & Smith, A. (2003) · Cell · doi:10.1016/s0092-8674(03)00847-x · Cited by 2,122
Non-Smad pathways in TGF-β signaling
Zhang, Y. E. (2009) · Cell Research · doi:10.1038/cr.2008.328 · Cited by 1,749
Deng, Z., Morse, J. H., Slager, S. L., Cuervo, N., Moore, K. J., Venetos, G., Kalachikov, S., Cayanis, E., Fischer, S. G., Barst, R. J., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/303059 · Cited by 1,206
Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism
Yu, P. B., Hong, C. C., Sachidanandan, C., Babitt, J. L., Deng, D. Y., Hoyng, S. A., Lin, H. Y., Bloch, K. D., & Peterson, R. T. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.2007.54 · Cited by 1,034
Specificity, versatility, and control of TGF-β family signaling
Derynck, R., & Budi, E. H. (2019) · Science Signaling · doi:10.1126/scisignal.aav5183 · Cited by 785
“For example, Smad6 and Smad7 can inhibit BMP-induced p38MAPK activation (306), and Smad6 was reported to inhibit TGF-b–induced TAK1, JNK, and p38 MAPK activation (307).”
BackgroundThe Bone Morphogenetic Protein System In Mammalian Reproduction
Shimasaki, S., Moore, R. K., Otsuka, F., & Erickson, G. F. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0007 · Cited by 741
Non-Smad Signaling Pathways of the TGF-β Family
Zhang, Y. E. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022129 · Cited by 697
Two major Smad pathways in TGF‐β superfamily signalling
Miyazawa, K., Shinozaki, M., Hara, T., Furuya, T., & Miyazono, K. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00599.x · Cited by 662
Mechanical regulation of bone remodeling
Wang, L., You, X., Zhang, L., Zhang, C., & Zou, W. (2022) · Bone Research · doi:10.1038/s41413-022-00190-4 · Cited by 641
“Alternatively, BMP2 signaling can be mediated by the TAK1-p38 kinase pathway.(198) BMP2 deficiency in osteoblasts results in osteopenia and bone strength reduction.”
BackgroundNohe, A., Hassel, S., Ehrlich, M., Neubauer, F., Sebald, W., Henis, Y. I., & Knaus, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m102750200 · Cited by 564
Signaling of transforming growth factor‐β family members through Smad proteins
Itoh, S., Itoh, F., Goumans, M., & ten Dijke, P. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01828.x · Cited by 529
Signal transduction of bone morphogenetic protein receptors
Nohe, A. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2003.08.011 · Cited by 514
Divergence and convergence of TGF‐β/BMP signaling
Miyazono, K., Kusanagi, K., & Inoue, H. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1080 · Cited by 505
Qi, X., Li, T.-G., Hao, J., Hu, J., Wang, J., Simmons, H., Miura, S., Mishina, Y., & Zhao, G.-Q. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401367101 · Cited by 440
Signaling Molecules in Nonfamilial Pulmonary Hypertension
Du, L., Sullivan, C. C., Chu, D., Cho, A. J., Kido, M., Wolf, P. L., Yuan, J. X.-J., Deutsch, R., Jamieson, S. W., & Thistlethwaite, P. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021650 · Cited by 400
Intracellular BMP Signaling Regulation in Vertebrates: Pathway or Network?
von Bubnoff, A., & Cho, K. W. Y. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0388 · Cited by 393
BMP signaling in skeletal development
Wan, M., & Cao, X. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.067 · Cited by 383
BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation
Retting, K. N., Song, B., Yoon, B. S., & Lyons, K. M. (2009) · Development · doi:10.1242/dev.029926 · Cited by 380
Sequential actions of BMP receptors control neural precursor cell production and fate
Panchision, D. M., Pickel, J. M., Studer, L., Lee, S.-H., Turner, P. A., Hazel, T. G., & McKay, R. D. G. (2001) · Genes & Development · doi:10.1101/gad.894701 · Cited by 327
Pathobiology of Pulmonary Hypertension
Rabinovitch, M. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.092033 · Cited by 301
TGF β Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis
Papageorgis, P. (2015) · Journal of Oncology · doi:10.1155/2015/587193 · Cited by 223
“TGFβ can also promote activation of the JNK and p38-MAPK pathways to regulate apoptosis or cell migration, depending on cellular context [91–93], via MKK4 and MKK3/6, respectively [94, 95].”
BackgroundRole of TGFβ in regulation of the tumor microenvironment and drug delivery (Review)
PAPAGEORGIS, P., & STYLIANOPOULOS, T. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2816 · Cited by 206
“Moreover, tgfβ can mediate the activation of the c-jun n-terminal kinase (jnK) and p38/mitogen-activated protein kinase (MaPK) pathways, which are responsible for promoting apoptosis or cell migration depending on cellular context (66-68), via the mitogen-activated protein kinase kinase (MKK)4 and 3/6, respectively (6…”
Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads
Itoh, F. (2001) · The EMBO Journal · doi:10.1093/emboj/20.15.4132 · Cited by 202
Transforming growth factor‐β signaling in cancer invasion and metastasis
Leivonen, S., & Kähäri, V. (2007) · International Journal of Cancer · doi:10.1002/ijc.23113 · Cited by 191
Lories, R. J. U., Derese, I., Ceuppens, J. L., & Luyten, F. P. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11389 · Cited by 165
VEGF, a prosurvival factor, acts in concert with TGF-β1 to induce endothelial cell apoptosis
Ferrari, G., Pintucci, G., Seghezzi, G., Hyman, K., Galloway, A. C., & Mignatti, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605556103 · Cited by 160
Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism
Schulz, T. J., & Tseng, Y.-H. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.10.019 · Cited by 154
“TAK1 in turn phosphorylates the MAPK kinase MKK6, which can directly phosphorylate p38MAPK (66).”
Background
Metadata
- Authors
- Kimura, N., Matsuo, R., Shibuya, H., Nakashima, K., & Taga, T.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-06
- Volume
- 275
- Issue
- 23
- Pages
- 17647-17652
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2076439289
- Cited by
- 240
- References
- 3
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.